Latest News
Waypoint Capital Acquires Majority Stake in Allergy Partners
Monday 20 December 2021

An affiliate of Jersey-based investment firm Waypoint Capital has acquired a 70% stake in Allergy Partners, the largest US group of single-specialty allergy and asthma practices, the firm said.

Allergy Partners will continue to be led by current chief executive officer, David Brown.

Terms of the transaction were not disclosed.

Allergy Partners was established in 1977 as a single-office practice in Western North Carolina and has grown to become the nation's premier allergy and asthma services platform.

Allergy Partners operates 62 practice hubs, comprising 135 physicians across 20 states.

Leveraging its network of hubs and physicians, Allergy Partners facilitates over 300,000 annual patient encounters.

McDermott Will and Emery acted as legal counsel and SVB Leerink acted as exclusive financial advisor to Waypoint.

Waypoint is a private investment firm that oversees growth-orientated operating businesses and partners with asset managers, always with an "active owner" philosophy.

Waypoint's other USA holdings include Gurnet Point Capital, a unique healthcare fund which invests long-term capital to enable a new generation of companies to grow and to unlock innovative and transformational healthcare solutions.
Date Published: 20/12/2021